Video Experimental Relacionado
Updated: Aug 18, 2026

06:31
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
Published on: May 20, 2015
La metástasis es el resultado de células variantes preexistentes dentro de un tumor maligno
Resumen
Las células de melanoma maligno murino mostraron una variación significativa en el potencial de metástasis pulmonar. Esto indica que el tumor original contenía variantes celulares preexistentes y altamente metastásicas.
Área de la Ciencia:
- Oncología Oncología.
- Investigación de las Metástasis del Cáncer.
- Estudios de Heterogeneidad Tumoral Estudios de Heterogeneidad Tumoral
Sus antecedentes:
- El melanoma maligno murino es un modelo significativo para el estudio de la progresión del cáncer.
- La heterogeneidad tumoral es un factor conocido que influye en la agresividad del cáncer y la respuesta al tratamiento.
Objetivo del estudio:
- Para investigar el potencial metastásico de clones derivados in vitro de una línea celular madre de melanoma maligno murino.
- Para determinar si las variantes preexistentes dentro de la población de tumores progenitoras contribuyen a la capacidad metastásica.
Principales métodos:
- Derivación de clones celulares in vitro de un cultivo de melanoma maligno murino progenitor.
- La inoculación intravenosa de estos clones en ratones singenéticos.
- Cuantificación de la formación de colonias metastásicas en los pulmones.
Principales resultados:
- Se observó una variabilidad significativa en las capacidades metastásicas entre diferentes clones.
- Algunos clones exhibieron una capacidad marcadamente mayor para formar metástasis pulmonares en comparación con otros.
Conclusiones:
- La población de melanoma maligno murino progenitor es heterogénea.
- Las variantes de células tumorales altamente metastásicas preexisten dentro de la población parental, lo que contribuye a la variabilidad metastásica observada.
Videos de Conceptos Relacionados
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

